DV
Dividend Vision

EXOZ — eXoZymes, Inc.

eXoZymes, Inc. (EXOZ)

Total return is -32.7% over the past 1.7 years, 65.4 points behind SPY at 32.7%. Its deepest 1-year drawdown was 73.3%.

eXoZymes, Inc. is a development stage biotechnology company that focuses on developing enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company does not currently distribute dividends to shareholders. This security appeals primarily to investors with a high risk tolerance who are interested in early-stage biotechnology ventures rather than those seeking current income.

EXOZ key facts

Asset type
Stock
Asset class
Equity
Inception date
11/13/2024
Last close
$5.82
Market cap
$55,873,780
Average volume
9100.0
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.15